Antimicrobial and Antiviral Peptides and Proteins: Discovery, Biotechnology and Therapeutic Applications
A Special Issue of Molecules (ISSN 1420-3049) belonging to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 June 2027 | Viewed by 20
Editors
Interests: production of recombinant proteins; lectins; heterologous expression systems; modern biotechnology techniques; biomedical applications
Special Issues, Collections and Topics in MDPI journals
Interests: polymer inclusion membranes; water and wastewater treatment; sorption; separation processes; biotechnology engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rapid emergence of antimicrobial resistance and the continuous threat of emerging and re-emerging viral infections highlight the urgent need for innovative anti-infective agents. Bioactive peptides and proteins, including antimicrobial and antiviral peptides, lectins, recombinant proteins, and other naturally derived or engineered biomolecules, have attracted increasing attention as promising alternatives or complements to conventional antimicrobial and antiviral therapies. This Special Issue aims to highlight recent advances in the discovery, characterization, production, engineering, and biomedical applications of bioactive peptides and proteins with antimicrobial and antiviral properties. Particular attention will be given to innovative approaches for recombinant production, including microbial and plant-based expression systems, protein engineering, structure–activity relationships, mechanisms of action, and strategies for improving stability, activity, specificity, and therapeutic potential. Contributions addressing antibacterial, antiviral, antifungal, and broad-spectrum anti-infective activities are welcome, as are studies on the development of peptide- and protein-based microbicides and other preventive or therapeutic approaches. Research on lectins and other bioactive proteins, recombinant biologics, novel expression and production platforms, formulation and delivery strategies, preclinical and clinical development, and translational applications is particularly encouraged. keywords: antimicrobial and antiviral peptides; bioactive proteins; lectins; recombinant proteins; protein engineering; antimicrobial and antiviral agents; viral infections; emerging viral diseases; therapeutic applications; microbicides
Dr. Katarzyna Bandurska
Dr. Iwona Zawierucha
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial and antiviral peptides
- bioactive proteins
- lectins
- recombinant proteins
- protein engineering
- antimicrobial and antiviral agents
- viral infections
- emerging viral diseases
- therapeutic applications
- microbicides
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
